Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Adagio Medical Holdings, Inc.ADGM · Entity 7926 | Chief Financial Officer | July 31, 2024 | August 01, 2024 |
| Hyperfine, Inc.HYPR · Entity 6865 | Director | May 22, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Adagio Medical Holdings, Inc.
Report date July 31, 2024 · Filed August 01, 2024
This filing explicitly reported no securities owned.
Hyperfine, Inc.
Report date May 22, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.49 · Expires 2036-05-22 | Direct | 157,700 |
Reported balance
After 2026-05-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-22 · Grant · Acquired 157,700 · Balance 157,700 F1: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2026 Filed May 22, 2026 20:34 UTC | Hyperfine, Inc. HYPR · Entity 6865 | GrantStock Options (right to buy) · Derivative | 157,700 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001193125-26-237050 · ownership.xml · derivative · entry 1 Dahldorf John T · CIK 0001365494 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,700 Underlying: Class A Common Stock · 157,700 shares Expires 2036-05-22 F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date. Read SEC document |
| May 20, 2025 Filed May 20, 2025 21:19 UTC | Hyperfine, Inc. HYPR · Entity 6865 | GrantStock Options (right to buy) · Derivative | 79,200 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0000950170-25-075367 · ownership.xml · derivative · entry 1 Dahldorf John T · CIK 0001365494 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,200 Underlying: Class A Common Stock · 79,200 shares Expires 2035-05-20 F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date. Read SEC document |
| June 12, 2024 Filed Jun 12, 2024 21:02 UTC | Hyperfine, Inc. HYPR · Entity 6865 | GrantStock Options (right to buy) · Derivative | 79,200 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-24-005849 · doc4.xml · derivative · entry 1 Dahldorf John T · CIK 0001365494 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,200 Underlying: Class A Common Stock · 79,200 shares Expires 2034-06-12 F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date. Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:31 UTC | Hyperfine, Inc. HYPR · Entity 6865 | GrantStock Options (right to buy) · Derivative | 85,000 | $0.00 Strike: $1.97 | $0.00 |
DisclosureSEC source: 0001209191-23-036335 · doc4.xml · derivative · entry 2 Dahldorf John T · CIK 0001365494 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Class A Common Stock · 85,000 shares Expires 2033-06-09 F2 · derivative.exercise_date: The shares underlying this option vest as to 50% on June 9, 2024 and the remaining 50% on June 9, 2025, subject to Mr. Dahldorf's continued service through the applicable vesting date. Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:31 UTC | Hyperfine, Inc. HYPR · Entity 6865 | GrantStock Options (right to buy) · Derivative | 112,000 | $0.00 Strike: $1.97 | $0.00 |
DisclosureSEC source: 0001209191-23-036335 · doc4.xml · derivative · entry 1 Dahldorf John T · CIK 0001365494 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,000 Underlying: Class A Common Stock · 112,000 shares Expires 2033-06-09 F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:09 UTC | Hyperfine, Inc. HYPR · Entity 6865 | GrantStock Options (right to buy) · Derivative | 85,345 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001209191-22-036277 · doc4.xml · derivative · entry 1 Dahldorf John T · CIK 0001365494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,345 Underlying: Class A Common Stock · 85,345 shares Expires 2032-06-09 F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date. Read SEC document |
| December 23, 2021 Filed Dec 24, 2021 02:40 UTC | Hyperfine, Inc. HYPR · Entity 6865 | GrantClass A Common Stock | 16,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-153330 · tm2135698-13_4seq1.xml · nonDerivative · entry 1 Dahldorf John T · CIK 0001365494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,483 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on December 23, 2022, subject to Mr. Dahldorf's continued service through the applicable vesting date. Read SEC document |
| December 23, 2021 Filed Jan 11, 2022 02:38 UTC Amendment | Hyperfine, Inc. HYPR · Entity 6865 | GrantClass A Common Stock | 19,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-002887 · tm222483-2_4aseq1.xml · nonDerivative · entry 1 Dahldorf John T · CIK 0001365494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,586 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on December 23, 2022, subject to Mr. Dahldorf's continued service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.